These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 32381646)
1. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4 Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646 [TBL] [Abstract][Full Text] [Related]
2. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation. Wang X; Wang W; Xu J; Le Q Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787 [TBL] [Abstract][Full Text] [Related]
3. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin. Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Yang H; Cheng EY; Sharma VK; Lagman M; Chang C; Song P; Ding R; Muthukumar T; Suthanthiran M Transplantation; 2012 Mar; 93(6):580-8. PubMed ID: 22270834 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats. Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590 [TBL] [Abstract][Full Text] [Related]
6. [Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model]. Zheng YX; Hou GH; Song J; Zhang C; Liang T Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):327-30. PubMed ID: 17428387 [TBL] [Abstract][Full Text] [Related]
7. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells. Wang X; Wang W; Xu J; Hong J; Le Q Exp Clin Transplant; 2013 Feb; 11(1):56-62. PubMed ID: 22769982 [TBL] [Abstract][Full Text] [Related]
9. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Tahvildari M; Omoto M; Chen Y; Emami-Naeini P; Inomata T; Dohlman TH; Kaye AE; Chauhan SK; Dana R Transplantation; 2016 Mar; 100(3):525-32. PubMed ID: 26881788 [TBL] [Abstract][Full Text] [Related]
10. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569 [TBL] [Abstract][Full Text] [Related]
11. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice. Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation. Pothoven KL; Kheradmand T; Yang Q; Houlihan JL; Zhang H; Degutes M; Miller SD; Luo X Am J Transplant; 2010 Aug; 10(8):1774-84. PubMed ID: 20626386 [TBL] [Abstract][Full Text] [Related]
13. [Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs]. Liang Y; Zhou G; Zhang L; Liu J; Zhong X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):15-9. PubMed ID: 26728371 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. Gagliani N; Gregori S; Jofra T; Valle A; Stabilini A; Rothstein DM; Atkinson M; Roncarolo MG; Battaglia M PLoS One; 2011; 6(12):e28434. PubMed ID: 22174806 [TBL] [Abstract][Full Text] [Related]
15. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells. Cong L; Wang SF; Zhao ZL; Yang RY Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069 [TBL] [Abstract][Full Text] [Related]
16. Novel sphingosine-1-phosphate receptor modulator KRP203 combined with locally delivered regulatory T cells induces permanent acceptance of pancreatic islet allografts. Khattar M; Deng R; Kahan BD; Schroder PM; Phan T; Rutzky LP; Stepkowski SM Transplantation; 2013 Apr; 95(7):919-27. PubMed ID: 23545505 [TBL] [Abstract][Full Text] [Related]
17. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
18. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media. Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model. Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800 [TBL] [Abstract][Full Text] [Related]
20. Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Monti P; Scirpoli M; Maffi P; Piemonti L; Secchi A; Bonifacio E; Roncarolo MG; Battaglia M Diabetes; 2008 Sep; 57(9):2341-7. PubMed ID: 18559659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]